Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FEPTJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,683
Award facts
- Contract value 100% obligated
- $5,682.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,682.96 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. The contract, issued on October 17, 2025, with an ultimate completion date of November 7, 2025, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected to fulfill this requirement under its existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
This delivery order is issued under the broader PPV-G GEN V acquisition strategy, a $30.3 billion program designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC under this program with a ceiling value of $499,999,999 and a completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. The company's substantial recent contracting activity with the Defense Logistics Agency's Medical Supply Chain division demonstrates its established capability to serve as a critical pharmaceutical supplier supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FEPTJ?
SPE2DB26FEPTJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FEPTJ worth?
The government has obligated $5,683 on SPE2DB26FEPTJ.
Is contract SPE2DB26FEPTJ an order under another contract?
Yes. SPE2DB26FEPTJ is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB26FEPTJ competed?
The extent of competition for SPE2DB26FEPTJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award